Dr. Hilary Baldwin, the director of the Acne Treatment and Research Center in Brooklyn, New York, discusses a low-dose formulation of isotretinoin designed for better absorption in patients with acne.
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York, discusses the history of isotretinoin and emerging treatments such as Absorica LD. He describes the adverse event profile of isotretinoin with increased triglycerides. He...
* a very small amount of patients who take Absorbica LD a year after finishing will require retreatment
https://www.absoricald.com/
Lawrence Green, MD, a board-certified dermatologist and clinical professor of dermatology at George Washington University School of Medicine, discusses...